PAH-Icon Symposia

Annual PAH-Icon meetings are usually held as a pre-conference session at the annual PVRI congress. The meetings bring together researchers and clinicians worldwide to share their latest findings on ??????. 

Held during....

 

Programme highlights

  • Keynote: Rare disease landscape in Brazil and Latin America - Roberto Giugliani
  • Update from ClinGen PAH gene and variant expert panel - Carrie Welch
  • Update from the TBX4Life initiative - Eric Austin
  • Late onset pulmonary veno-occlusive disease associated with rare heterozygous variants of KDR and EIF2AK4 - Vasile Foris
  • Functional characterization of novel KV1.5 variants in PAH - Andrea Olschewski
  • Spatial profiling identifies localised changes in gene expression in pulmonary vascular remodeling in the sugen hypoxia rat model - James Klinger
  • Pathogenic PAH gene variants linked to pulmonary vascular pruning in non-hispanic white COPD gene participants - Vasile Foris
  • Smaller right ventricular volumes correlate with elevated afterload in unaffected carriers of a pathogenic BMPR2 variant - Eszter Tóth
  • Building future PH cohorts
    • Examples and experiences from around the globe
    • PVRI GoDeep’s future perspective
    • Core data set: Standardisation & harmonisation of phenotypes
    • Leveraging image data
    •  Resources, federation & analy

Held during....

Programme highlights

  • Integration of genetics & omics data into risk calculators - Anna Hemnes
  • Deciphering the genetic basis of Systemic Sclerosis - Javier Martin
  • Genetics of the right ventricle - Khodr Tello
  • Panel discussion: Opportunities for artificial intelligence in PV research - Dennis Wang, Andrew Sweatt, Khodr Tello
  • Seven additional patients with SOX17-related PAH & review of the literature - Natalia Gallego-Zazo
  • BMPR2 mutation and prognosis in PAH: a monocentric experience - Fabio Sirchia
  • A rare case of PAH associated with a TBX4 mutation in a patient treated with dasatinib - Fabio Sirchia
  • Pulmonary vascular phenotype in patients with GDF2 (BMP9) or BMP10 variants: a multicentre study - Julien Grynblat
  • SMAD6 as a possible cause of a congenital heart disease associated PAH - Christina Eichstaedt
  • Phenotypic characterisation of SOX17-related PAH in children - Cara Morgan
  • Hereditary PAH – Genetics and environmental exposure untangled - Christina Eichstaedt